,
Fisher, Jacqueline Horan
Becan, Jennifer E.
Harris, Philip W.
Nager, Alexis
Baird-Thomas, Connie
Hogue, Aaron
Bartkowski, John P.
Wiley, Tisha
Funding for this research was provided by:
National Institute on Drug Abuse (U01DA036221)
National Institute on Drug Abuse (U01DA036226)
National Institute on Drug Abuse (U01DA036233)
National Institute on Drug Abuse (U01DA036176)
National Institute on Drug Abuse (U01DA036225)
National Institute on Drug Abuse (U01DA036224)
National Institute on Drug Abuse (U01DA036158)
Article History
Received: 2 January 2018
Accepted: 26 March 2018
First Online: 30 April 2018
Ethics approval and consent to participate
: Ethic approval was granted by the Institutional Review Boards (IRB) of Texas Christian University (#1410–106-1411), University of Kentucky, Mississippi State University (#13–205), Emory University (#77541), Columbia University (#6765), and Temple University (#22451). All aspects of the research study were explained to all participants and informed consent was obtained, in concordance with the IRB protocols at each of these research centers.
: Not applicable.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.